These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9669282)

  • 61. New ideas on pathology of restenosis.
    Phillips DF
    JAMA; 1996 May; 275(17):1299-300. PubMed ID: 8614099
    [No Abstract]   [Full Text] [Related]  

  • 62. Restenosis--an open file.
    Gottsauner-Wolf M; Moliterno DJ; Lincoff AM; Topol EJ
    Clin Cardiol; 1996 May; 19(5):347-56. PubMed ID: 8723592
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis.
    Mintz GS; Popma JJ; Hong MK; Pichard AD; Kent KM; Satler LF; Leon MB
    Am J Cardiol; 1996 Aug; 78(3A):18-22. PubMed ID: 8751842
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Update on PTCA: what are its limitations? Can they be overcome by new devices? A look at atherectomy, intra-arterial stents, and laser catheters.
    Feldman T; Moscucci M
    J Crit Illn; 1993 Apr; 8(4):461-78. PubMed ID: 10148463
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanisms of acute coronary syndromes and the potential role of statins.
    Dupuis J
    Atheroscler Suppl; 2001 Feb; 2(1):9-14. PubMed ID: 11286155
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The basis of molecular strategies for treating coronary restenosis after angioplasty.
    Epstein SE; Speir E; Unger EF; Guzman RJ; Finkel T
    J Am Coll Cardiol; 1994 May; 23(6):1278-88. PubMed ID: 8176084
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Plaque disruption and thrombosis: potential role of inflammation and infection.
    Shah PK
    Cardiol Rev; 2000; 8(1):31-9. PubMed ID: 11174871
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Relation between activated smooth-muscle cells in coronary-artery lesions and restenosis after atherectomy.
    Simons M; Leclerc G; Safian RD; Isner JM; Weir L; Baim DS
    N Engl J Med; 1993 Mar; 328(9):608-13. PubMed ID: 8429852
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pathophysiology of coronary artery restenosis.
    Schwartz RS; Henry TD
    Rev Cardiovasc Med; 2002; 3 Suppl 5():S4-9. PubMed ID: 12478229
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Microribonucleic acids for prevention of plaque rupture and in-stent restenosis: "a finger in the dam".
    O'Sullivan JF; Martin K; Caplice NM
    J Am Coll Cardiol; 2011 Jan; 57(4):383-9. PubMed ID: 21251577
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Histological patterns of atherosclerotic plaques in unstable angina patients vary according to clinical presentation.
    Mann JM; Kaski JC; Pereira WI; Arie S; Ramires JA; Pileggi F
    Heart; 1998 Jul; 80(1):19-22. PubMed ID: 9764053
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Atherothrombosis: mechanisms and clinical therapeutic approaches.
    Fuster V; Badimon JJ; Chesebro JH
    Vasc Med; 1998; 3(3):231-9. PubMed ID: 9892516
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interrelation between atherosclerosis and restenosis.
    Kranzhöfer R; Libby P
    Z Kardiol; 1995; 84 Suppl 4():125-8. PubMed ID: 8585264
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Atherogenesis and thrombosis: mechanisms, pathogenesis, and therapeutic implications.
    Clark LT
    Am Heart J; 1992 Apr; 123(4 Pt 2):1106-9. PubMed ID: 1553879
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled Evaluation.
    Karsch KR; Preisack MB; Baildon R; Eschenfelder V; Foley D; Garcia EJ; Kaltenbach M; Meisner C; Selbmann HK; Serruys PW; Shiu MF; Sujatta M; Bonan R
    J Am Coll Cardiol; 1996 Nov; 28(6):1437-43. PubMed ID: 8917255
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Regulation of smooth muscle cell proliferation and its possible role in preventing restenosis post-angioplasty.
    Nikol S; Höfling B
    Wien Klin Wochenschr; 1995; 107(13):379-89. PubMed ID: 7638968
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Pathophysiology and pathobiochemistry of restenosis].
    Höfling B; Gonschior P; Nikol S; Bauriedel G; Welsch U; Nerlich A
    Z Kardiol; 1994 May; 83(5):313-8. PubMed ID: 8053238
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesions.
    MacLeod DC; Strauss BH; de Jong M; Escaned J; Umans VA; van Suylen RJ; Verkerk A; de Feyter PJ; Serruys PW
    J Am Coll Cardiol; 1994 Jan; 23(1):59-65. PubMed ID: 8277096
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pathophysiological insights from studies of retrieved coronary atherectomy tissue.
    Glover C; O'Brien ER
    Semin Interv Cardiol; 2000 Dec; 5(4):167-73. PubMed ID: 11176010
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular biology: insight into the causes and prevention of restenosis after arterial intervention.
    Wilcox JN
    Am J Cardiol; 1993 Oct; 72(13):88E-95E. PubMed ID: 8213576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.